There are 30,000 - 50,000 stores who will be advertising ZICAM in their weekly newspaper inserts. These include Walmart, K-mart, Target, Albertson's (second largest grocery store in the US), Rite Aide, and the list goes on and on. ADVERTISING by these marketing powerhouses will attract buyers of Zicam. Ancedotal/testimonial evidence that Zicam eliminates colds from 10-14 days to around 2 days will spread like wildfire through families, networks of friends, and people at the work place. This is happening because Zicam does eliminate the cold to an average of 1.5 days used as directed.
One clinical study has been completed. Another study, being conducted
at a major univeristy in California will have their's complete next month. Both studies will be submitted for publication. Once the "scientific" community has been informed, GUMM shares will become
extrememly valuable. I'm glad to own before this all happens.
GUMM's NET PROFIT per sale is around $1.80
So we are talking extremely high profit margins for the very best product used against the most common illness - the common cold.
As time goes on, we will see continued buying by Hedge Funds
and other mutual funds. This is history in the making in which
I'm glad to be an investor early on. In following years, Zicam
will penetrate the $3 Billion US cold market further. Its also a big world out there and cold sufferers in other countries will have access to Zicam after its launch in America.
$ Net profit: $1.80 per sale x number of colds.
Regards,
S.W.
|
